Used as a key intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules. Its boron-containing group enables Suzuki-Miyaura cross-coupling reactions, making it valuable in constructing complex organic frameworks for drug discovery. Commonly employed in research settings to introduce functionalized piperazine and furan moieties into target compounds, enhancing molecular diversity and binding affinity. Also utilized in the preparation of potential candidates for central nervous system therapies due to the piperazine unit’s prevalence in neuroactive drugs.